Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 8, 1999

View Archived Issues

Lorus Therapeutics announces preclinical data on anticancer compound

Ilex Oncology focuses on anticancer drugs

Micrologix Biotech continues preclinical testing on acne drugs

Genelabs Technologies' DARPA drug discovery grant renewed

Gastric antisecretory and gastroprotective compounds in development at Byk Gulden

Merck researchers design tachykinin antagonists particularly useful as antiemetics

FDA awards fast track designation to Trimeris's HIV fusion inhibitor

Antiulcer benzimidazoles discovered by Dr. Reddy's group

Novartis describes new PNP inhibitor series in recent patent literature

Purinoceptor P2 receptor antagonists in early development at Astra

Second-generation NNRTIs show promising resistance profile, pharmacokinetics in preclinical studies

Orphan Medical's Busulfex Injection approved in U.S.

Ex vivo studies explain disappointing results with antiadhesion therapy in stroke patients

Boston Life Sciences identifies a second antiangiogenic molecule

Lubeluzole shows good safety but no efficacy in large trial in acute stroke patients

Sch-217048: potent and selective neurokinin antagonist from natural sources

Ligand receives FDA approval for Ontak as CTCL treatment

Preclinical profile of novel antimigraine agent SB-220453 described

Emadine approved for conjunctivitis in Europe

UCB files NDA for levetiracetam

Kitasato investigators discover new microbial-based compound for atherosclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...